Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care Delivery, Digital Transformation, Precision Medicine, Remote Monitoring and Telehealth.

RSS icon
Ultra-high-res MRI Reveals Migraine Brain Changes

Hackensack Meridian teams up with AI specialists for brain tumor care

The partnership is just the latest example of AI technologies being adopted in the healthcare space.

Thumbnail

Eli Lilly caps insulin costs at $35 per month

The company announced price reductions of 70% for its most commonly prescribed insulins.

Medicare money payment physician

Hospitals still facing financial struggles in 2023

Hospital margins were -1% in January 2023, compared to -0.7% in December 2022. 

 

Thumbnail

DEA proposes restricting some telemedicine prescriptions

The proposed rules specifically narrow the prescribing of controlled substances via telemedicine for patients who have not been seen in person.

FDA authorizes first at-home flu and COVID-19 test

The test specifically can detect and differentiate between influenza A and B and the SARS-Cov-2 virus that causes COVID-19.

Emotional rescue: AI app interprets feelings of the nonverbal

A healthcare AI startup spawned from academia has launched an app to help caregivers understand the emotional state of individuals who are minimally verbal due to such conditions as autism, brain injury and dementia.

New ransomware threat with ties to Russia targets healthcare providers

The "prolific" ransomware group Clop is associated with Russia and has managed to breach some major healthcare systems.

Pfizer in talks to acquire Seagen in deal worth more than $30B

Pharmaceutical giant Pfizer is reportedly in talks to acquire Seagen, a biotechnology company focused on developing cancer therapies.

Displaying 569 - 576 of 5132

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup